Limits...
The BRI-on-chip disposable test device opens up substantial savings potentials in urolithiasis treatment

View Article: PubMed Central - HTML

AUTOMATICALLY GENERATED EXCERPT
Please rate it.

EU-citizens suffer from that symptom which burdens the healthcare systems by several tens of billions of Euros yearly... Stone formation is the result of an altered urinary composition, mostly caused by an underlying metabolic disease and disadvantageously interacting external risk factors... Mostly, no specific long-term therapy for prevention of recurrence follows the purely symptom-based stone removal... The consequence is a diagnostic and therapeutic under-supply which inevitably results in a vicious circle of recurrent stone formation, although the recurrence rate can be lowered from 80% without metaphylaxis down to 20% under risk-adopted therapy... However, to date no simple, cost-effective and precise method to determine the crystal formation risk of a native urine exists on the market... Whereas the former are very satisfied about the Urolizer, the latter two asked again for a simplified BRI test device... The disposable “BRI-on-Chip” meets particularly the requirements of the resident doctors... The result is presented in three levels within a few seconds... The BRI-on-Chip approach perfectly fits both the medical and socio-economical needs as: (1) an inexpensive, reliable, intuitively and easy-to-use diagnostic tool for the evaluation of the urinary stone formation risk is given to the physicians allowing them to better apply an appropriate stone metaphylaxis, and (2) it helps to reduce the continuously increasing urolithiasis-related costs as the recurrence rates will be consecutively lowered... It can be expected, that the BRI-principle allows also for the screening of other metabolic diseases.

No MeSH data available.


The BRI facilitates to leave the vicious circle.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4125860&req=5

Figure 1: The BRI facilitates to leave the vicious circle.


The BRI-on-chip disposable test device opens up substantial savings potentials in urolithiasis treatment
The BRI facilitates to leave the vicious circle.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4125860&req=5

Figure 1: The BRI facilitates to leave the vicious circle.

View Article: PubMed Central - HTML

AUTOMATICALLY GENERATED EXCERPT
Please rate it.

EU-citizens suffer from that symptom which burdens the healthcare systems by several tens of billions of Euros yearly... Stone formation is the result of an altered urinary composition, mostly caused by an underlying metabolic disease and disadvantageously interacting external risk factors... Mostly, no specific long-term therapy for prevention of recurrence follows the purely symptom-based stone removal... The consequence is a diagnostic and therapeutic under-supply which inevitably results in a vicious circle of recurrent stone formation, although the recurrence rate can be lowered from 80% without metaphylaxis down to 20% under risk-adopted therapy... However, to date no simple, cost-effective and precise method to determine the crystal formation risk of a native urine exists on the market... Whereas the former are very satisfied about the Urolizer, the latter two asked again for a simplified BRI test device... The disposable “BRI-on-Chip” meets particularly the requirements of the resident doctors... The result is presented in three levels within a few seconds... The BRI-on-Chip approach perfectly fits both the medical and socio-economical needs as: (1) an inexpensive, reliable, intuitively and easy-to-use diagnostic tool for the evaluation of the urinary stone formation risk is given to the physicians allowing them to better apply an appropriate stone metaphylaxis, and (2) it helps to reduce the continuously increasing urolithiasis-related costs as the recurrence rates will be consecutively lowered... It can be expected, that the BRI-principle allows also for the screening of other metabolic diseases.

No MeSH data available.